Molecular basis of sugar recognition by collectin-K1 and the effects of mutations associated with 3MC syndrome

Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue...

Full description

Saved in:
Bibliographic Details
Published inBMC biology Vol. 13; no. 1; p. 27
Main Authors Venkatraman Girija, Umakhanth, Furze, Christopher M, Gingras, Alexandre R, Yoshizaki, Takayuki, Ohtani, Katsuki, Marshall, Jamie E, Wallis, A Katrine, Schwaeble, Wilhelm J, El-Mezgueldi, Mohammed, Mitchell, Daniel A, Moody, Peter C E, Wakamiya, Nobutaka, Wallis, Russell
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 17.04.2015
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly(204)Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals. In this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca(2+) binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca(2+) during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder. We have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca(2+) binding during biosynthesis.
AbstractList Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca.sup.2+-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly.sup.204Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals. In this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca.sup.2+ binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca.sup.2+ during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder. We have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca.sup.2+ binding during biosynthesis.
Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly(204)Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals. In this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca(2+) binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca(2+) during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder. We have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca(2+) binding during biosynthesis.
Background Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca.sup.2+-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly.sup.204Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals. Results In this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca.sup.2+ binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca.sup.2+ during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder. Conclusions We have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca.sup.2+ binding during biosynthesis. Keywords: Complement activation, structural biology, C-type lectin, 3MC syndrome
Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly(204)Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals.BACKGROUNDCollectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to carbohydrates on pathogens to activate the lectin pathway of complement and together with its associated serine protease MASP-3 serves as a guidance cue for neural crest development. High serum levels are associated with disseminated intravascular coagulation, where spontaneous clotting can lead to multiple organ failure. Autosomal mutations in the CL-K1 or MASP-3 genes cause a developmental disorder called 3MC (Carnevale, Mingarelli, Malpuech and Michels) syndrome, characterised by facial, genital, renal and limb abnormalities. One of these mutations (Gly(204)Ser in the CL-K1 gene) is associated with undetectable levels of protein in the serum of affected individuals.In this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca(2+) binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca(2+) during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder.RESULTSIn this study, we show that CL-K1 primarily targets a subset of high-mannose oligosaccharides present on both self- and non-self structures, and provide the structural basis for its ligand specificity. We also demonstrate that three disease-associated mutations prevent secretion of CL-K1 from mammalian cells, accounting for the protein deficiency observed in patients. Interestingly, none of the mutations prevent folding or oligomerization of recombinant fragments containing the mutations in vitro. Instead, they prevent Ca(2+) binding by the carbohydrate-recognition domains of CL-K1. We propose that failure to bind Ca(2+) during biosynthesis leads to structural defects that prevent secretion of CL-K1, thus providing a molecular explanation of the genetic disorder.We have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca(2+) binding during biosynthesis.CONCLUSIONSWe have established the sugar specificity of CL-K1 and demonstrated that it targets high-mannose oligosaccharides on self- and non-self structures via an extended binding site which recognises the terminal two mannose residues of the carbohydrate ligand. We have also shown that mutations associated with a rare developmental disorder called 3MC syndrome prevent the secretion of CL-K1, probably as a result of structural defects caused by disruption of Ca(2+) binding during biosynthesis.
ArticleNumber 27
Audience Academic
Author Gingras, Alexandre R
Mitchell, Daniel A
Wallis, A Katrine
Wallis, Russell
Venkatraman Girija, Umakhanth
Yoshizaki, Takayuki
El-Mezgueldi, Mohammed
Schwaeble, Wilhelm J
Ohtani, Katsuki
Moody, Peter C E
Furze, Christopher M
Marshall, Jamie E
Wakamiya, Nobutaka
Author_xml – sequence: 1
  givenname: Umakhanth
  surname: Venkatraman Girija
  fullname: Venkatraman Girija, Umakhanth
  email: uvg1@leicester.ac.uk, uvg1@leicester.ac.uk
  organization: Department of Biochemistry, University of Leicester, Leicester, LE1 9HN, UK. uvg1@leicester.ac.uk
– sequence: 2
  givenname: Christopher M
  surname: Furze
  fullname: Furze, Christopher M
  email: cf178@leicester.ac.uk
  organization: Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, LE1 9HN, UK. cf178@leicester.ac.uk
– sequence: 3
  givenname: Alexandre R
  surname: Gingras
  fullname: Gingras, Alexandre R
  email: agingras@ucsd.edu, agingras@ucsd.edu
  organization: Department of Medicine, University of California San Diego, La Jolla, CA, 92093-0726, USA. agingras@ucsd.edu
– sequence: 4
  givenname: Takayuki
  surname: Yoshizaki
  fullname: Yoshizaki, Takayuki
  email: tyoshizaki@bt.fubt.fukuyama-u.ac.jp
  organization: Department of Microbiology and Immunochemistry, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan. tyoshizaki@bt.fubt.fukuyama-u.ac.jp
– sequence: 5
  givenname: Katsuki
  surname: Ohtani
  fullname: Ohtani, Katsuki
  email: ohtani@asahikawa-med.ac.jp
  organization: Department of Microbiology and Immunochemistry, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan. ohtani@asahikawa-med.ac.jp
– sequence: 6
  givenname: Jamie E
  surname: Marshall
  fullname: Marshall, Jamie E
  email: jm286@leicester.ac.uk
  organization: Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, LE1 9HN, UK. jm286@leicester.ac.uk
– sequence: 7
  givenname: A Katrine
  surname: Wallis
  fullname: Wallis, A Katrine
  email: ab4292@coventry.ac.uk
  organization: Department of Applied Science and Health, Coventry University, Coventry, CV1 5FB, UK. ab4292@coventry.ac.uk
– sequence: 8
  givenname: Wilhelm J
  surname: Schwaeble
  fullname: Schwaeble, Wilhelm J
  email: ws5@le.ac.uk
  organization: Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, LE1 9HN, UK. ws5@le.ac.uk
– sequence: 9
  givenname: Mohammed
  surname: El-Mezgueldi
  fullname: El-Mezgueldi, Mohammed
  email: mem16@le.ac.uk
  organization: Department of Biochemistry, University of Leicester, Leicester, LE1 9HN, UK. mem16@le.ac.uk
– sequence: 10
  givenname: Daniel A
  surname: Mitchell
  fullname: Mitchell, Daniel A
  email: D.Mitchell@warwick.ac.uk
  organization: Clinical Sciences Research Laboratories, Warwick Medical School, University Hospital Coventry & Warwickshire Coventry, Coventry, CV2 2DX, UK. D.Mitchell@warwick.ac.uk
– sequence: 11
  givenname: Peter C E
  surname: Moody
  fullname: Moody, Peter C E
  email: pcem1@leicester.ac.uk
  organization: Department of Biochemistry, University of Leicester, Leicester, LE1 9HN, UK. pcem1@leicester.ac.uk
– sequence: 12
  givenname: Nobutaka
  surname: Wakamiya
  fullname: Wakamiya, Nobutaka
  email: wakamiya@asahikawa-med.ac.jp
  organization: Department of Microbiology and Immunochemistry, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan. wakamiya@asahikawa-med.ac.jp
– sequence: 13
  givenname: Russell
  surname: Wallis
  fullname: Wallis, Russell
  email: rw73@le.ac.uk, rw73@le.ac.uk
  organization: Department of Biochemistry, University of Leicester, Leicester, LE1 9HN, UK. rw73@le.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25912189$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vFSEUhiemxn7oD3BjSNzUxVQO88HMxqS50drYpok2bgkDh7mYGagDo95_X-be2vQmLoQQ4PC8b-BwjrMD5x1m2WugZwBN_T4Aa6HK6XYUdc6eZUfAS8g5pfzgyfowOw7hB6Ws4rx4kR2yqgUGTXuUuWs_oJoHOZFOBhuINyTMfdpOqHzvbLTekW5DlB8SGK3LvwCRTpO4RoLGpNhWNM5RLmwgMgSvrIyoyW8b16S4XpGwcXryI77Mnhs5BHz1MJ9kt58-3q4-51c3F5er86tc1ZTGnDFU0OiqxpYyWdYGNEXFO6k6xWvT6oJVrEtNS665Lg036WmAEnRjdFecZB92tndzN6JW6OIkB3E32VFOG-GlFfsnzq5F73-JsiwAeJMMTh8MJv9zxhDFaIPCYZAO_RwE1A2wumwrntC3O7SXAwrrjE-OasHFeVVCWS13TdTZP6jUNY5WpW81NsX3BO_2BImJ-Cf2cg5BXH77-v_szfd9FnasmnwIE5rHrAAVS1WJXVUJuh1FLRbNm6fpfFT8LaPiHoNeyb4
CitedBy_id crossref_primary_10_3390_ijms25052508
crossref_primary_10_1681_ASN_2017050544
crossref_primary_10_1016_j_imbio_2016_05_012
crossref_primary_10_1111_imr_12468
crossref_primary_10_3389_fimmu_2019_02238
crossref_primary_10_3389_fimmu_2018_02238
crossref_primary_10_3389_fimmu_2023_1328658
crossref_primary_10_1016_j_kint_2023_11_031
crossref_primary_10_1016_j_molimm_2018_06_011
crossref_primary_10_1016_j_imbio_2022_152263
crossref_primary_10_1172_jci_insight_159452
crossref_primary_10_1007_s10875_019_00714_4
crossref_primary_10_1021_acs_biomac_7b00228
crossref_primary_10_1007_s00467_020_04588_2
crossref_primary_10_1111_bph_15307
crossref_primary_10_3390_cancers12071792
crossref_primary_10_1096_fj_201901582R
crossref_primary_10_3390_biom11020188
crossref_primary_10_1002_art_41696
crossref_primary_10_1111_cei_12678
crossref_primary_10_3389_fimmu_2020_585243
crossref_primary_10_3390_life13040985
crossref_primary_10_3389_fimmu_2018_01757
crossref_primary_10_3389_fimmu_2023_1185208
crossref_primary_10_3390_biomedicines9040391
crossref_primary_10_1016_j_molimm_2019_06_007
crossref_primary_10_1111_jcmm_15046
crossref_primary_10_3389_fneur_2023_1159658
crossref_primary_10_1371_journal_pgen_1006679
crossref_primary_10_3389_fimmu_2023_1297352
crossref_primary_10_1007_s00281_017_0642_0
crossref_primary_10_1371_journal_pntd_0007324
crossref_primary_10_1016_j_sbi_2017_04_002
crossref_primary_10_1074_jbc_RA119_010271
Cites_doi 10.1016/S0969-2126(94)00124-3
10.4049/jimmunol.165.3.1403
10.1016/S0167-5699(97)01207-3
10.1016/0008-6215(94)84015-6
10.1083/jcb.201312042
10.1186/bcr1305
10.1016/S0021-9258(17)40708-3
10.1107/S0907444909052925
10.1111/j.1348-0421.2006.tb03868.x
10.1107/S0907444910048675
10.1107/S0907444904019158
10.1038/ng.757
10.1146/annurev.bi.65.070196.002301
10.1126/science.1066371
10.1016/S0969-2126(99)80036-7
10.1016/j.molimm.2013.07.011
10.1093/glycob/cwq020
10.1107/S0021889807021206
10.1369/jhc.7A7312.2007
10.1107/S0907444996012255
10.1371/journal.pone.0000623
10.1159/000345356
10.1042/bj3250391
10.1126/science.1721241
10.4049/jimmunol.1002185
10.1007/s11239-013-1042-5
10.1107/S0907444994003112
10.1016/j.jmb.2009.09.057
10.1038/360127a0
10.1016/j.sbi.2014.07.003
10.1021/bi981972a
10.4049/jimmunol.1302121
10.1074/jbc.274.6.3580
10.1093/nar/19.16.4485
10.1021/bi9819733
10.1039/C2CS35382B
10.1160/TH14-05-0457
ContentType Journal Article
Copyright COPYRIGHT 2015 BioMed Central Ltd.
Venkatraman Girija et al.; licensee BioMed Central. 2015
Copyright_xml – notice: COPYRIGHT 2015 BioMed Central Ltd.
– notice: Venkatraman Girija et al.; licensee BioMed Central. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
7X8
5PM
DOI 10.1186/s12915-015-0136-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1741-7007
ExternalDocumentID A541453252
10_1186_s12915_015_0136_2
25912189
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0700859
– fundername: Medical Research Council
  grantid: G0801952
– fundername: NIGMS NIH HHS
  grantid: GM62116
– fundername: Medical Research Council
  grantid: G0501425
– fundername: Medical Research Council
  grantid: G1000191/1
– fundername: NIGMS NIH HHS
  grantid: U54 GM062116
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
4.4
53G
5GY
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
8G5
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
IOV
ISE
ISR
ITC
KQ8
LK8
M1P
M2O
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
PADUT
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
CITATION
AFPKN
7X8
5PM
ID FETCH-LOGICAL-c600t-22ec18d56e902a46f1d0ec7bacbc76f9d3252bbbbda7d7d4f7f2571ea1d8fdb3
IEDL.DBID RPM
ISSN 1741-7007
IngestDate Tue Sep 17 21:14:49 EDT 2024
Thu Nov 28 02:03:24 EST 2024
Tue Nov 19 21:29:54 EST 2024
Tue Nov 12 23:34:23 EST 2024
Sat Sep 28 21:31:25 EDT 2024
Sat Sep 28 20:54:24 EDT 2024
Thu Nov 21 21:19:57 EST 2024
Thu Nov 28 21:32:04 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-22ec18d56e902a46f1d0ec7bacbc76f9d3252bbbbda7d7d4f7f2571ea1d8fdb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431178/
PMID 25912189
PQID 1681264957
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4431178
proquest_miscellaneous_1681264957
gale_infotracmisc_A541453252
gale_infotracacademiconefile_A541453252
gale_incontextgauss_ISR_A541453252
gale_incontextgauss_IOV_A541453252
crossref_primary_10_1186_s12915_015_0136_2
pubmed_primary_25912189
PublicationCentury 2000
PublicationDate 2015-04-17
PublicationDateYYYYMMDD 2015-04-17
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-04-17
  day: 17
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC biology
PublicationTitleAlternate BMC Biol
PublicationYear 2015
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References ME Taylor (136_CR23) 2014; 28C
R Wallis (136_CR30) 1997; 325
CT Heise (136_CR20) 2000; 165
Collaborative Computational Project N (136_CR36) 1994; 50
AJ McCoy (136_CR32) 2007; 40
MA Johnson (136_CR22) 2013; 42
AK Shrive (136_CR19) 2009; 394
KBM Reid (136_CR7) 1998; 12
WI Weis (136_CR10) 1992; 360
TG Battye (136_CR31) 2011; 67
C Rooryck (136_CR6) 2011; 43
M Franchini (136_CR25) 2014; 112
PD Adams (136_CR37) 2010; 66
KK Ng (136_CR11) 1998; 37
A Ruggiano (136_CR21) 2014; 204
DC Dunlop (136_CR27) 2010; 20
W Motomura (136_CR2) 2008; 56
WI Weis (136_CR9) 1994; 2
RJ Kaufman (136_CR29) 1991; 19
S Hansen (136_CR3) 2010; 185
A Krarup (136_CR26) 2007; 2
K Hakansson (136_CR33) 1999; 7
GN Murshudov (136_CR35) 1997; 53
ML Henriksen (136_CR13) 2013; 56
R Wallis (136_CR28) 1999; 274
YJ Ma (136_CR4) 2013; 5
136_CR16
P Emsley (136_CR34) 2004; 60
H Feinberg (136_CR17) 2001; 294
K Takahashi (136_CR5) 2014; 38
Z Madjd (136_CR24) 2005; 7
D Fu (136_CR15) 1994; 261
WI Weis (136_CR18) 1996; 65
H Keshi (136_CR1) 2006; 50
ML Henriksen (136_CR8) 2013; 191
KK Ng (136_CR12) 1998; 37
ST Iobst (136_CR14) 1994; 269
WI Weis (136_CR38) 1991; 254
References_xml – volume: 2
  start-page: 1227
  year: 1994
  ident: 136_CR9
  publication-title: Structure.
  doi: 10.1016/S0969-2126(94)00124-3
  contributor:
    fullname: WI Weis
– volume: 165
  start-page: 1403
  year: 2000
  ident: 136_CR20
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.165.3.1403
  contributor:
    fullname: CT Heise
– volume: 12
  start-page: 56
  year: 1998
  ident: 136_CR7
  publication-title: Immunol Today.
  doi: 10.1016/S0167-5699(97)01207-3
  contributor:
    fullname: KBM Reid
– volume: 261
  start-page: 173
  year: 1994
  ident: 136_CR15
  publication-title: Carbohydr Res.
  doi: 10.1016/0008-6215(94)84015-6
  contributor:
    fullname: D Fu
– volume: 204
  start-page: 869
  year: 2014
  ident: 136_CR21
  publication-title: J Cell Biol.
  doi: 10.1083/jcb.201312042
  contributor:
    fullname: A Ruggiano
– ident: 136_CR16
– volume: 7
  start-page: 780
  year: 2005
  ident: 136_CR24
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr1305
  contributor:
    fullname: Z Madjd
– volume: 269
  start-page: 15505
  year: 1994
  ident: 136_CR14
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)40708-3
  contributor:
    fullname: ST Iobst
– volume: 66
  start-page: 213
  year: 2010
  ident: 136_CR37
  publication-title: Acta Crystallogr D Biol Crystallogr.
  doi: 10.1107/S0907444909052925
  contributor:
    fullname: PD Adams
– volume: 50
  start-page: 1001
  year: 2006
  ident: 136_CR1
  publication-title: Microbiol Immunol.
  doi: 10.1111/j.1348-0421.2006.tb03868.x
  contributor:
    fullname: H Keshi
– volume: 67
  start-page: 271
  year: 2011
  ident: 136_CR31
  publication-title: Acta Crystallogr D Biol Crystallogr.
  doi: 10.1107/S0907444910048675
  contributor:
    fullname: TG Battye
– volume: 60
  start-page: 2126
  year: 2004
  ident: 136_CR34
  publication-title: Acta Crystallogr D Biol Crystallogr.
  doi: 10.1107/S0907444904019158
  contributor:
    fullname: P Emsley
– volume: 43
  start-page: 197
  year: 2011
  ident: 136_CR6
  publication-title: Nat Genet.
  doi: 10.1038/ng.757
  contributor:
    fullname: C Rooryck
– volume: 65
  start-page: 441
  year: 1996
  ident: 136_CR18
  publication-title: Annu Rev Biochem.
  doi: 10.1146/annurev.bi.65.070196.002301
  contributor:
    fullname: WI Weis
– volume: 294
  start-page: 2163
  year: 2001
  ident: 136_CR17
  publication-title: Science.
  doi: 10.1126/science.1066371
  contributor:
    fullname: H Feinberg
– volume: 7
  start-page: 255
  year: 1999
  ident: 136_CR33
  publication-title: Structure.
  doi: 10.1016/S0969-2126(99)80036-7
  contributor:
    fullname: K Hakansson
– volume: 56
  start-page: 757
  year: 2013
  ident: 136_CR13
  publication-title: Mol Immunol.
  doi: 10.1016/j.molimm.2013.07.011
  contributor:
    fullname: ML Henriksen
– volume: 20
  start-page: 812
  year: 2010
  ident: 136_CR27
  publication-title: Glycobiology.
  doi: 10.1093/glycob/cwq020
  contributor:
    fullname: DC Dunlop
– volume: 40
  start-page: 658
  year: 2007
  ident: 136_CR32
  publication-title: J Appl Crystallogr.
  doi: 10.1107/S0021889807021206
  contributor:
    fullname: AJ McCoy
– volume: 56
  start-page: 243
  year: 2008
  ident: 136_CR2
  publication-title: J Histochem Cytochem.
  doi: 10.1369/jhc.7A7312.2007
  contributor:
    fullname: W Motomura
– volume: 53
  start-page: 240
  year: 1997
  ident: 136_CR35
  publication-title: Acta Crystallogr D Biol Crystallogr.
  doi: 10.1107/S0907444996012255
  contributor:
    fullname: GN Murshudov
– volume: 2
  year: 2007
  ident: 136_CR26
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0000623
  contributor:
    fullname: A Krarup
– volume: 5
  start-page: 242
  year: 2013
  ident: 136_CR4
  publication-title: J Innate Immun.
  doi: 10.1159/000345356
  contributor:
    fullname: YJ Ma
– volume: 325
  start-page: 391
  year: 1997
  ident: 136_CR30
  publication-title: Biochem J.
  doi: 10.1042/bj3250391
  contributor:
    fullname: R Wallis
– volume: 254
  start-page: 1608
  year: 1991
  ident: 136_CR38
  publication-title: Science.
  doi: 10.1126/science.1721241
  contributor:
    fullname: WI Weis
– volume: 185
  start-page: 6096
  year: 2010
  ident: 136_CR3
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1002185
  contributor:
    fullname: S Hansen
– volume: 38
  start-page: 331
  year: 2014
  ident: 136_CR5
  publication-title: J Thromb Thrombolysis.
  doi: 10.1007/s11239-013-1042-5
  contributor:
    fullname: K Takahashi
– volume: 50
  start-page: 760
  year: 1994
  ident: 136_CR36
  publication-title: Acta Cryst D Biol Crystallogr
  doi: 10.1107/S0907444994003112
  contributor:
    fullname: Collaborative Computational Project N
– volume: 394
  start-page: 776
  year: 2009
  ident: 136_CR19
  publication-title: J Mol Biol.
  doi: 10.1016/j.jmb.2009.09.057
  contributor:
    fullname: AK Shrive
– volume: 360
  start-page: 127
  year: 1992
  ident: 136_CR10
  publication-title: Nature.
  doi: 10.1038/360127a0
  contributor:
    fullname: WI Weis
– volume: 28C
  start-page: 14
  year: 2014
  ident: 136_CR23
  publication-title: Curr Opin Struct Biol.
  doi: 10.1016/j.sbi.2014.07.003
  contributor:
    fullname: ME Taylor
– volume: 37
  start-page: 17965
  year: 1998
  ident: 136_CR11
  publication-title: Biochemistry.
  doi: 10.1021/bi981972a
  contributor:
    fullname: KK Ng
– volume: 191
  start-page: 6117
  year: 2013
  ident: 136_CR8
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1302121
  contributor:
    fullname: ML Henriksen
– volume: 274
  start-page: 3580
  year: 1999
  ident: 136_CR28
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.274.6.3580
  contributor:
    fullname: R Wallis
– volume: 19
  start-page: 4485
  year: 1991
  ident: 136_CR29
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/19.16.4485
  contributor:
    fullname: RJ Kaufman
– volume: 37
  start-page: 17977
  year: 1998
  ident: 136_CR12
  publication-title: Biochemistry.
  doi: 10.1021/bi9819733
  contributor:
    fullname: KK Ng
– volume: 42
  start-page: 4327
  year: 2013
  ident: 136_CR22
  publication-title: Chem Soc Rev.
  doi: 10.1039/C2CS35382B
  contributor:
    fullname: MA Johnson
– volume: 112
  start-page: 1103
  year: 2014
  ident: 136_CR25
  publication-title: Thromb Haemost.
  doi: 10.1160/TH14-05-0457
  contributor:
    fullname: M Franchini
SSID ssj0025773
Score 2.3641238
Snippet Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca(2+)-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to...
Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca.sup.2+-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds to...
Background Collectin-K1 (CL-K1, or CL-11) is a multifunctional Ca.sup.2+-dependent lectin with roles in innate immunity, apoptosis and embryogenesis. It binds...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 27
SubjectTerms Abnormalities, Multiple - genetics
Analysis
Animals
Calcium - metabolism
Carbohydrates - chemistry
Cattle
Cells
CHO Cells
Collectins - chemistry
Collectins - genetics
Collectins - metabolism
Complement Activation
Cricetinae
Cricetulus
Crystallography, X-Ray
Disaccharides - metabolism
Genetic aspects
Glycoproteins - metabolism
Humans
Kinetics
Ligands
Models, Molecular
Mutant Proteins - metabolism
Mutation - genetics
Physiological aspects
Protein Binding
Protein Biosynthesis
Protein Structure, Secondary
Protein Structure, Tertiary
Rats
Syndrome
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFA9jIvgi8_vqlCiCIESbNE3aB5ExHFO5CrrJ3kKajznQdK634P3vPacfl1Xmi4U8lJxAe_JLzjnN6e8Q8jxkvka_gkkITpjkzrFKZjnzHoyHk5kr-nJAy0_q8Fh-OClOtshU3mpUYHtlaIf1pI4vfrz6_Wv9Fhb8m37Bl-p1CzaLYwoatlwx2JGvCTCMmOG1lJtDBQCnzseDzSuHITFwUXEwetXMSv29V18yVvNEykuW6WCH3BxdSro3YOAW2QrpNrk-FJlc3yFpOVXApWCyzlraRNp2p3C7SR5qEq3XFCGB219iHzm1yVPwDemY74GDfnbDsX1L7TinwVP8jkvz5T6dqA_ukqODd0f7h2ysssAcODsrJkRwvPSFClUmrFSR-yw4XVtXO61i5XNRiBoub7XXXkYdQZM8WO7LCBN9j2ynJoUHhGa5rWNVRFXrKJHJ1EPIW4gyBhu4y4sFeTkp1ZwPXBqmj0FKZYbJMFnfcmXEgjxDtRvkqEiYBHNqu7Y17z9_M3tYurzAx_qX0NcvM6EXo1BsYJacHX88gIdG7quZ5O5MElaam3U_nSBgsAvT01JoutZwZHFTEGvqBbk_QGLzhhOkFkTPwLIRQILveU86-94TfUsAMdflw_8e-YjcED2-JeN6l2yvLrrwGJyoVf2kXxp_AD4sGy4
  priority: 102
  providerName: Scholars Portal
Title Molecular basis of sugar recognition by collectin-K1 and the effects of mutations associated with 3MC syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/25912189
https://www.proquest.com/docview/1681264957
https://pubmed.ncbi.nlm.nih.gov/PMC4431178
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJSqGX0ne2SRe1FAoFZy1bD_uYLAlpi9OwTcvSi5D1SBe6cojXh_z7jvxY4kIvNchgNAZZM_I3Y3-aQei9jU0Z_IqIQnASUaJ1lNM4jYwB8NA01qwtB1Rc8PPv9POSLXcQG_bCtKR9Xa6O_O_1kV_9armVN2s9G3his8tiTgH1iMhmu2gX4HcI0fsoiwmR9r8vScZnNQAaCfy00FIehfI14PITgLZ8hEV_v5HvQdKYLnkPf86eoMe944iPuwE-RTvWP0MPu1KSd8-RL4Y6txiAaVXjyuG6uYbLLUWo8ri8w0Hx4SXnoy8EK28weIC4Z3WEm9ZN93O-xqrXnDU4fK3FaTHHQ4KDF-jq7PRqfh71tRQiDS7NJkoSq0lmGLd5nCjKHTGx1aJUutSCu9ykCUtKOIwSRhjqhIOZJFYRkzlQ50u05ytv9xGOU1W6nDleCkdDvlIDgS1LMmeVJTplE_RxmFR502XMkG2kkXHZKUPGbUu5TCboXZh2GTJR-EB1uVZNXctPX3_I41CgnIVh_Uvo22Ik9KEXchVoSat-ewEMOmS4GkkejiRhPelR99vBBGToCiQ0b6umliTkauMQUYoJetWZxPYJB5OaIDEylq1ASOM97gHrbtN599b8-r_vPECPkta-aUTEIdrb3Db2DbhKm3IKC2QppujByenF5WLafnCAc0EzOC9Ofk7bpfMHjkkZOw
link.rule.ids 230,314,727,780,784,864,885,24318,27924,27925,31720,33745,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYIL4lm2FDAICQnJ3TjxIzlWK6ot7RYEC-rNcvwoK7FO1WwO_feM81g1SFyIlEPkseR4xv5mks8zCL13iS2jX0EYBCeEUWNIwZKMWAvgYVhieFsOaHEu5j_Y5wt-sYP4cBamJe2bcnUYfq8Pw-pXy628WpvpwBObfl3MGKAelfn0DrrLM1nQIUjv4ywuZdb_wKS5mNYAaTQy1OKdCRIL2IDTTwHcihEa_b0n3wKlMWHyFgIdP0IPe9cRH3VDfIx2XHiC7nXFJG-eorAYKt1igKZVjSuP6-YSHrckoSrg8gZH1cdtLpBTinWwGHxA3PM6Yqd10_2er7Hudecsjt9rcbaY4SHFwTO0PP60nM1JX02BGHBqNiRNnaG55cIVSaqZ8NQmzshSm9JI4QubpTwt4bJaWmmZlx5mkjpNbe5Boc_RbqiCe4FwkunSF9yLUnoWM5ZaCG15mnunHTUZn6CPw6Sqqy5nhmpjjVyoThkqae9MqHSC3sVpVzEXRYhkl0vd1LU6-fJTHcUS5TwO619C37-NhD70Qr4CLRndHzCAQcccVyPJg5EkrCgzan47mICKTZGGFlzV1IrGbG0CYko5QXudSWzfcDCpCZIjY9kKxETe4xaw7zahd2_P-__d8w26P18uztTZyfnpS_QgbW2dESoP0O7munGvwHHalK_bZfIHYLEXMQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMQF8SwLBQxCQkJyEyd-ZI_VwqqlbKmgoN4sx4-yEuusyObQf884j9UGiQuRfIg8kRzPZ89M_GUGobcutWX0KwiD4IQwagyZsjQn1oLxMCw1vC0HtDgTx9_Zp0t-uVPqqyXtm3J5GH6tDsPyZ8utXK9MMvDEkvPFjIHVo7JI1tYnN9EtngPIhkC9j7W4lHl_iEkLkdRg1mhkqcWWCxKL2IDjT8HATUcW6e99eccwjUmTO1Zofh_d691HfNQN8wG64cJDdLsrKHn9CIXFUO0Wg3la1rjyuG6u4HZLFKoCLq9xVH_c6gI5pVgHi8EPxD23Iz60aroj-hrrXn_O4vjNFueLGR7SHDxGF_OPF7Nj0ldUIAYcmw3JMmdoYblw0zTTTHhqU2dkqU1ppPBTm2c8K-GyWlppmZceZpI6TW3hQalP0F6ognuKcJrr0k-5F6X0LGYttRDe8qzwTjtqcj5B74dJVesub4Zq441CqE4ZKm1bLlQ2QW_itKuYjyJEwsuVbupanXz5oY5imXIeh_UvoW9fR0LveiFfgZaM7n8ygEHHPFcjyYORJKwqM-p-PUBAxa5IRQuuampFY8Y2AXGlnKD9DhLbNxwgNUFyBJatQEzmPe4BjLdJvXtMP_vvJ1-hO-cf5urzydnpc3Q3a6HOCJUHaG_zu3EvwHfalC_bVfIHWMwYRA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+basis+of+sugar+recognition+by+collectin-K1+and+the+effects+of+mutations+associated+with+3MC+syndrome&rft.jtitle=BMC+biology&rft.au=Venkatraman+Girija%2C+Umakhanth&rft.au=Furze%2C+Christopher+M&rft.au=Gingras%2C+Alexandre+R&rft.au=Yoshizaki%2C+Takayuki&rft.date=2015-04-17&rft.pub=BioMed+Central&rft.eissn=1741-7007&rft.volume=13&rft_id=info:doi/10.1186%2Fs12915-015-0136-2&rft_id=info%3Apmid%2F25912189&rft.externalDBID=PMC4431178
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7007&client=summon